Blocking neuroblastoma cell growth
An inhibitor of cell metabolism may be a good therapeutic target for neuroblastoma
MYC proteins drive neuroblastoma tumorigenesis in part by promoting the expression of key glycolytic enzymes such as LDHA to induce aerobic glycolysis (a type of cellular metabolism).
Dai Chung , M.D., and colleagues tested the effects of FX11, a selective inhibitor of LDHA, in a series of neuroblastoma cell lines. They found that FX11 inhibited aerobic glycolysis and growth in neuroblastoma cell lines with single-copy and amplified MYC genes. FX11 caused cell cycle arrest and induction of programmed cell death in the neuroblastoma cell lines.
The findings demonstrate that LDHA is a potential target for the development of novel neuroblastoma treatments and suggest that LDHA antagonists should be further tested in preclinical neuroblastoma models.
Original publication
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.